Marco Boscaro

Q: What Schools Are Affiliated With Marco Boscaro

Marco Boscaro is affiliated with the following schools: University of Padua

Marco Boscaro's AcademicInfluence.com Rankings

Marco Boscaro

Computer Science

#8458

World Rank

#8891

Historical Rank

Machine Learning

#3468

World Rank

#3511

Historical Rank

Artificial Intelligence

#3768

World Rank

#3823

Historical Rank

Database

#5463

World Rank

#5667

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Marco Boscaro Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Marco Boscaro's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. (2006) (1233)
Diagnosis and complications of Cushing's syndrome: a consensus statement. (2003) (1010)
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. (2008) (618)
Prevalence and natural history of adrenal incidentalomas. (2003) (569)
Risk factors and long-term follow-up of adrenal incidentalomas. (1999) (278)
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. (2009) (274)
Risk factors and long-term outcome in pituitary-dependent Cushing's disease. (1996) (266)
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines (2004) (246)
Approach to the patient with possible Cushing's syndrome. (2009) (216)
Expanding role of AMPK in endocrinology (2006) (209)
Molecular genetic studies of sporadic pituitary tumors. (1994) (208)
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. (1998) (203)
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. (2005) (196)
Quality of life of hirsute women. (1993) (193)
Ketoconazole treatment in Cushing's syndrome: experience in 34 patients (1991) (186)
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. (2002) (182)
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study (2007) (175)
II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. (1997) (174)
Left ventricular structural and functional characteristics in Cushing's syndrome. (2003) (168)
Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. (2009) (167)
Development of overt Cushing's syndrome in patients with adrenal incidentaloma. (2002) (166)
Aldosterone as a cardiovascular risk factor (2005) (158)
AMP‐activated protein kinase mediates glucocorticoid‐ induced metabolic changes: a novel mechanism in Cushing's syndrome (2008) (158)
Diagnosis of primary aldosteronism: from screening to subtype differentiation (2005) (157)
LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study. (2014) (152)
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. (1993) (148)
Pathophysiology of Dyslipidemia in Cushing’s Syndrome (2010) (147)
Clinical Correlates of Major Depression in Cushing’s Disease (1998) (146)
Diagnosis and management of primary aldosteronism (2008) (137)
Role of nitric oxide concentrations on human sperm motility. (2004) (136)
Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. (2004) (122)
Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. (1998) (122)
Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. (2004) (117)
Diagnosis and management of adrenal incidentalomas. (2000) (115)
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. (2010) (114)
Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. (2015) (114)
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term (2018) (114)
Life events in the pathogenesis of Graves' disease. A controlled study. (1993) (109)
Prolonged treatment of Cushing's disease by ketoconazole. (1985) (105)
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. (1999) (103)
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol (2006) (102)
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency (2020) (101)
The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state (1992) (100)
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma (2017) (100)
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. (2018) (96)
Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. (2001) (93)
Persistent Psychological Distress in Patients Treated for Endocrine Disease (2004) (92)
Glucocorticoid-dependent hypertension (1992) (92)
Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism (2012) (90)
The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings. (2000) (86)
Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome (2004) (85)
Increased Factor VIII Associated Activities in Cushing's Syndrome: A Probable Hypercoagulable State (1982) (84)
Further Studies on the Hypercoagulable State of Patients with Cushing’s Syndrome (1985) (84)
Adrenocortical carcinoma: experience in 45 patients. (1997) (81)
Cardiovascular Risk In Cushing's Syndrome (2005) (79)
I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. (1997) (77)
Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications (2012) (76)
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. (2008) (75)
Personality characteristics and quality of life in patients treated for Cushing's syndrome (2006) (73)
Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects. (2010) (73)
Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease. (1993) (72)
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. (2006) (71)
Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man. (1998) (70)
Left ventricular structural characteristics in Cushing's syndrome. (1994) (70)
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) (68)
Adipose tissue 11β-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing’s syndrome (2006) (67)
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. (2003) (66)
P450c17 deficiency: clinical and molecular characterization of six patients. (2007) (65)
Managing Cushing’s disease: the state of the art (2014) (65)
Medical therapy for Cushing's disease. (1999) (65)
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease. (2010) (64)
Sexual Symptoms in Endocrine Diseases: Psychosomatic Perspectives (2007) (63)
IN VIVO AND IN VITRO STUDIES ON THE EFFECT OF METOCLOPRAMIDE ON ALDOSTERONE SECRETION (1980) (63)
Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. (1996) (62)
Harmful effects of functional hypercortisolism: a working hypothesis (2014) (62)
Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study (2017) (61)
The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. (2009) (61)
Bone health and aldosterone excess (2013) (61)
Correlates of perceived health related quality of life in obese, overweight and normal weight older adults: an observational study (2014) (60)
Testosterone and cardiovascular risk (2013) (59)
Self Image and Quality of Life in Acromegaly (2004) (58)
Coagulopathy in Cushing’s Syndrome (2010) (58)
Investigations on the morphology and function of adrenocortical tissue regenerated from gland capsular fragments autotransplanted in the musculus gracilis of the rat. (1990) (57)
Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS. (2015) (56)
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center (2015) (55)
A role for life events in the pathogenesis of Cushing's disease (1993) (55)
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single‐centre experience (2015) (55)
A Clinical Index for Rating Severity in Cushing’s Syndrome (2000) (54)
Life events in the pathogenesis of hyperprolactinemia. (2004) (54)
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas (2010) (53)
Effect of natural early menopause on bone mineral density. (2008) (53)
Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. (1981) (52)
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype (2017) (52)
Acute and chronic effects of high glucocorticoid levels on hypothalamic-pituitary-thyroid axis in man (1992) (50)
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors (2017) (49)
Analysis of the 11β-Hydroxysteroid Dehydrogenase Type 2 Gene (HSD11B2) in Human Essential Hypertension (2005) (48)
Cushing’s Syndrome: Screening and Diagnosis (2016) (48)
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome. (2012) (47)
The production of peroxynitrite by human spermatozoa may affect sperm motility through the formation of protein nitrotyrosine. (2006) (47)
Effect of surgical treatment on hypertension in Cushing's syndrome. (1996) (46)
Extended treatment of Cushing’s disease with pasireotide: results from a 2-year, Phase II study (2013) (46)
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension trial (2014) (45)
Psychosocial impairment in patients treated for pituitary disease: a controlled study (2007) (45)
Raloxifene: bone and cardiovascular effects. (2005) (45)
Geographic variation and evolution of immunosuppressive genes in a Drosophila parasitoid (1999) (45)
Clinical and molecular study in congenital muscular dystrophy with partial laminin α2 (LAMA2) deficiency (2003) (44)
Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase. (2003) (44)
RESPONSE OF PITUITARY‐ADRENAL AXIS TO CORTICOTROPHIN RELEASING HORMONE IN PATIENTS WITH CUSHING'S DISEASE BEFORE AND AFTER KETOCONAZOLE TREATMENT (1987) (43)
Adrenal incidentaloma. (2012) (43)
Corticotrophin‐releasing hormone and desmopressin tests in the differential diagnosis between Cushing’s disease and pseudo‐Cushing state: a comparative study (2011) (42)
Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. (2011) (42)
Evaluation of circulating thyroid‐specific transcripts as markers of thyroid cancer relapse (2004) (42)
Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's syndrome (1993) (42)
The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice. (2014) (41)
Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations (2012) (40)
Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants. (2010) (40)
Perioperative thromboprophylaxis in Cushing’s disease: What we did and what we are doing? (2015) (40)
Bone complications in patients with Cushing’s syndrome: looking for clinical, biochemical, and genetic determinants (2014) (39)
Multiple endocrine neoplasia type 1 and adrenal lesions. (2001) (39)
Adipose Tissue as an Endocrine Organ? A Review of Recent Data Related to Cardiovascular Complications of Endocrine Dysfunctions (2004) (39)
Recovery of Bone Mineral Density after Surgical Cure, but not by Ketoconazole Treatment, in Cushing’s Syndrome (2001) (39)
A Single-Center 10-Year Experience with Pasireotide in Cushing’s Disease: Patients’ Characteristics and Outcome (2016) (38)
Effect of the Serotonin Antagonists Ritanserin and Ketanserin in Cushing's Disease (2000) (38)
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome (2016) (37)
Slow-Release Lanreotide Treatment in Acromegaly: Effects on Quality of Life (1999) (36)
Metyrapone treatment in Cushing’s syndrome: a real-life study (2018) (36)
Estrogen and thyroid cancer is a stem affair: A preliminary study. (2017) (36)
Early adrenal hypofunction in patients with organ-specific autoantibodies and no clinical adrenal insufficiency. (1994) (36)
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis (2008) (35)
Free thiols in human spermatozoa: are Na+/K+-ATPase, Ca2+-ATPase activities involved in sperm motility through peroxynitrite formation? (2009) (35)
Reduced expression of the growth hormone and type 1 insulin‐like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor (2003) (35)
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. (2009) (35)
Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Placebo-controlled study of subjects sensitized to toluene diisocyanate. (1993) (35)
Coenzyme Q10 and male infertility (2009) (34)
Oleoylethanolamide Protects Human Sperm Cells from Oxidation Stress: Studies on Cases of Idiopathic Infertility1 (2006) (33)
Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women. (2009) (33)
Inactivation of the p16 tumor suppressor gene in adrenocortical tumors. (1999) (33)
Vascular endothelial growth factor and microvessel density in periodontitis patients with and without diabetes. (2009) (33)
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome (2016) (33)
Skin and thigh muscle metastasis from papillary thyroid cancer. (2009) (32)
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors (2014) (32)
Have androgen receptor gene CAG and GGC repeat polymorphisms an effect on sperm motility in infertile men? (2014) (31)
Gene therapy for thyroid cancer (2004) (31)
Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer. (2002) (31)
Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. (2014) (31)
Evidence for ultra-short loop autoregulation of adrenocorticotropin secretion in man. (1988) (31)
Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome. (2006) (31)
24-hour blood pressure profile in Addison's disease. (1994) (31)
Clotting changes in Cushing's syndrome: elevated factor VIII activity. (1983) (31)
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion (2019) (31)
Reduced nitric oxide levels in acromegaly: cardiovascular implications (2005) (30)
Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) (29)
Endocrine aspects of cancer gene therapy. (2004) (29)
Pharmacologic Management (2005) (29)
Pharmacologic Management of Cushing Syndrome (2005) (29)
Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas. (1999) (29)
Clinical use of pasireotide for Cushing’s disease in adults (2015) (29)
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers. (2011) (29)
Selective venous sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome. (1992) (28)
Adrenal incidentaloma: Surgical update (2007) (28)
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma. (2008) (28)
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. (2016) (28)
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” (2019) (28)
25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese (2016) (27)
In vitro evidence for local generation of renin and angiotensin II/III immunoreactivity by the human adrenal gland. (1991) (27)
Effect of serotonin on plasma aldosterone in man (1982) (27)
Insulin autoimmune syndrome (Hirata’s disease) in an Italian patient: a case report and review of the literature (2017) (27)
First-line screening tests for Cushing’s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS (2017) (27)
Up-to 5-year efficacy of pasireotide in a patient with Cushing’s disease and pre-existing diabetes: literature review and clinical practice considerations (2015) (27)
EFFECT OF BROMOCRIPTINE IN PITUITARY‐DEPENDENT CUSHING'S SYNDROME (1983) (26)
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation (2010) (26)
STRESSFUL LIFE EVENTS IN THE PATHOGENESIS OF CUSHING'S SYNDROME (1988) (26)
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma (2018) (26)
Chemical‐physical properties of lipoproteins in anorexia nervosa (2004) (25)
Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell line. (1996) (25)
New perspectives for gene therapy in endocrinology. (2000) (25)
Sexual dysfunctions in men affected by autoimmune Addison's disease before and after short-term gluco- and mineralocorticoid replacement therapy. (2013) (25)
Plasma renin activity and urinary aldosterone in Cushing's syndrome. (1978) (25)
Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women (2005) (24)
Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing’s disease (2013) (24)
Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas. (2001) (24)
Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors (2018) (24)
Regression of cardiac abnormalities after replacement therapy in Addison's disease. (1999) (24)
Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists. (2012) (24)
Cushing's syndrome (2001) (24)
An in vitro stimulatory effect of indoleamines on aldosterone biosynthesis in the rat. (1982) (23)
Paclitaxel Is an Effective Antiproliferative Agent on the Human NCI-H295 Adrenocortical Carcinoma Cell Line (1998) (23)
Effect of ketanserin in primary aldosteronism. (1985) (23)
Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism (2011) (23)
Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies (1982) (23)
Adipose cell–adrenal interactions: current knowledge and future perspectives (2008) (23)
Role of bilateral adrenalectomy in Cushing's disease (1994) (22)
Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma. (2009) (22)
Venous thrombosis and tissue plasminogen activator release deficiency: a family study (1991) (22)
Pharmacologic management of Cushing syndrome : new targets for therapy. (2005) (21)
The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways (2014) (21)
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC (2015) (21)
Management of primary aldosteronism: its complications and their outcomes after treatment. (2009) (21)
Idiopathic infertility: susceptibility of spermatozoa to in-vitro capacitation, in the presence and the absence of palmitylethanolamide (a homologue of anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. (2003) (21)
Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension. (2005) (20)
Idiopathic infertility: effect of palmitoylethanolamide (a homologue of anandamide) on hyperactivated sperm cell motility and Ca2+ influx. (2005) (20)
Coenzyme Q10 and male infertility. (2009) (20)
Pasireotide for the treatment of Cushing's disease (2010) (20)
Age and the metabolic syndrome affect salivary Cortisol rhythm: data from a community sample (2015) (20)
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy (2018) (20)
Changes in body composition and insulin sensitivity in severely obese subjects after laparoscopic adjustable silicone gastric banding (LASGB). (2005) (19)
Scintigraphic patterns of adrenocortical carcinoma: morpho-functional correlates. (2001) (19)
Licorice Ameliorates Postural Hypotension Caused by Diabetic Autonomic Neuropathy (1994) (19)
Role of raloxifene on platelet metabolism and plasma lipids (2008) (19)
Opioid modulation of normal and pathological human chromaffin tissue. (1986) (19)
Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing’s syndrome (1987) (19)
ReviewCushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas (2010) (19)
THE NATURAL HISTORY OF AUTOIMMUNE ADDISON'S DISEASE FROM THE DETECTION OF AUTOANTIBODIES TO DEVELOPMENT OF THE DISEASE: A LONG FOLLOW-UP STUDY ON 143 PATIENTS. (2019) (18)
GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gsp. (1995) (18)
Comment--Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma? (1999) (18)
Patients with Cushing's disease achieve normal urinary cortisol with LCI699, a potent 11[beta]-hydroxylase inhibitor: preliminary results from a multicenter, proof-of-concept study (2012) (18)
In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. (2003) (18)
A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma. (2005) (18)
Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders (2010) (18)
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. (2022) (17)
Coexistence of aldosteronoma and contralateral nonfunctioning adrenal adenoma in primary aldosteronism. (1997) (17)
Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison’s disease on glucocorticoid and mineralocorticoid replacement therapy (2018) (17)
Anaplastic Thyroid Carcinoma (2012) (17)
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells (2015) (17)
Adrenal morpho-functional alterations in patients with acromegaly (2008) (17)
Skeletal effect of natural early menopause. (2010) (16)
Genetic Studies in Familial Aldosteronism Not Suppressible by Dexamethasone (2000) (16)
Fine-needle aspiration cytology of adrenal masses: A re-assessment with histological confirmation (2012) (16)
Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism. (1981) (16)
Genetic mutations in thyroid carcinoma. (2009) (16)
Human Corticotropin-Releasing Hormone tests: 10 years of real-life experience in pituitary and adrenal disease. (2020) (16)
Defects of steroidogenesis (2010) (16)
Investigation of N-cadherin/β-catenin expression in adrenocortical tumors (2016) (15)
Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor (2018) (15)
Low-dose ketoconazole treatment in hirsute women (1990) (15)
Frequently asked questions and answers (if any) in patients with adrenal incidentaloma (2021) (15)
Plasma renin activity and urinary aldosterone in acromegaly (1979) (15)
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH‐dependent Cushing's syndrome (2017) (15)
New Insight into the Hypercoagulability of Cushing’s Syndrome (2011) (15)
Zona fasciculata-like histotype and aldosterone response to upright posture are not related in aldosterone-producing adenomas. (2009) (15)
Steroids and hypertension (1991) (15)
Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension. (2011) (15)
Effect of ketanserin on the in vitro regulation of aldosterone. (1986) (15)
Expression of growth hormone‐releasing hormone receptor splicing variants in human primary adrenocortical tumours (2005) (14)
The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing’s disease: findings from a pilot study (2015) (14)
Evaluation of angiotensin II type‐1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role (2018) (14)
Circadian secretion of ACTH, cortisol, and mineralocorticoids in Cushing's syndrome. (1982) (14)
Adrenocortical carcinoma: epidemiology and natural history. (1995) (14)
Effect of octreotide on 24-h blood pressure profile in acromegaly. (1998) (14)
Psychological distress and quality of life in endocrine disease. (1990) (14)
Microalbuminuria, brain vasomotor reactivity, carotid and kidney arterial flow in Type 2 diabetes mellitus. (2004) (14)
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines (2019) (14)
Improved salivary cortisol rhythm with dual-release hydrocortisone. (2018) (13)
Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI (2016) (13)
Incidentally Discovered Adrenal Tumors: Endocrine and Scintographic Correlates (1998) (13)
Coexistence of Aldosteronoma and Contralateral Nonfunctioning Adrenal Adenoma in Primary Aldosteronism (1997) (13)
Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study (2018) (13)
Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation. (2008) (13)
Disseminated nocardiosis in a patient with Cushing’s syndrome (1994) (12)
Corticotropin-Releasing Effect of Hexarelin, a Peptidyl GH Secretagogue, in Normal Subjects Pretreated with Metyrapone or RU-486, a Glucocorticoid Receptor Antagonist, and in Patients with Addison’s Disease (1999) (12)
A multidisciplinary approach to the management of adrenal incidentaloma (2021) (12)
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line (2016) (12)
Inhibition of Pituitary β-Endorphin by ACTH and Glucocorticoids (1990) (12)
Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN) (2020) (12)
Adrenal incidentaloma: effects on bone metabolism. (2008) (11)
New aspects of mineralocorticoid hypertension. (1990) (11)
Potential therapeutic effects of ritanserin in Cushing's disease. (1992) (10)
Effect of alpha-human atrial natriuretic peptide in low renin essential hypertension and primary aldosteronism. (1987) (10)
In vitro studies on the effects of ranitidine on isolated anterior pituitary and adrenal cells. (1981) (10)
Is this a seizure? (2017) (10)
ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies. (1987) (10)
Potential indications for somatostatin analogs in Cushing's syndrome. (2005) (10)
Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome. (1985) (10)
Long-term treatment of Cushing's disease with pasireotide (SOM230): results from a Phase II extension study (2010) (10)
Evidence for ectopic ACTH production years after bilateral adrenalectomy for Cushing’s syndrome: in vivo and in vitro studies (1985) (9)
Percutaneous Therapy of Varicocele: Effects on Semen Parameters in Young Adults (2004) (9)
Metyrapone Treatment in Endogenous Cushing’s Syndrome: Results at Week 12 From PROMPT, a Prospective International Multicenter, Open-Label, Phase III/IV Study (2021) (9)
New treatment guidelines on Cushing's disease (2009) (9)
Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof‐of‐concept study (2018) (9)
Peripheral and renal vein plasma renin activity in hypertensive urological patients. (1982) (9)
Increase in vascular permeability produced in rat airways by PAF: potentiation by adrenalectomy (1992) (9)
Vitamin D levels and bone mineral density: are LH levels involved in the pathogenesis of bone impairment in hypogonadal men? (2014) (9)
Abnormality of aldosterone and cortisol late pathways in glucocorticoid-remediable aldosteronism. (1994) (8)
Medical Treatment for Acromegaly does not Increase the Risk of Central Adrenal Insufficiency: A Long-Term Follow-Up Study (2016) (8)
Increased factor VIII/vWf levels in patients with reduced platelet number (1987) (8)
Intrapituitary cytokines in Cushing’s disease: do they play a role? (2011) (8)
Growth hormone deficiency in the transition period: Body composition and gonad function (2011) (8)
Indication to dynamic and invasive testing in Cushing’s disease according to different neuroradiological findings (2021) (8)
The role of psychological well-being in obese and overweight older adults (2015) (8)
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model (2019) (8)
Association of primary aldosteronism with chronic thyroiditis (2016) (8)
Lipoproteins Obtained from Anorexia Nervosa Patients Induce Higher Oxidative Stress in U373MG Astrocytes Through Nitric Oxide Production (2007) (7)
Atrial natriuretic peptide in Cushing’s disease (1990) (7)
Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus (2004) (7)
Fracture risk assessment before and after resolution of endogenous hypercortisolism: Is the FRAX® algorithm useful? (2014) (7)
Anxiety sensitivity in essential hypertension (1992) (7)
MALE FACTOR Coenzyme Q 10 treatment in infertile men with idiopathic asthenozoospermia : a placebo-controlled , double-blind randomized trial (2009) (7)
Body Composition is Different After Surgical or Pharmacological Remission of Cushing’s Syndrome: A Prospective DXA Study (2017) (7)
Effect of a single injection of testosterone enanthate on 17β estradiol and bone turnover markers in hypogonadal male patients (2015) (6)
Improved salivary cortisol rhythm with dual-release hydrocortisone (2018) (6)
Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion. (1993) (6)
New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing's syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography. (2020) (6)
Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors (2015) (6)
Human leucocytes in asthenozoospermic patients: endothelial nitric oxide synthase expression (2014) (6)
Aldosterone, calcium, and hypertension. (1986) (6)
Possible efficacy of Lavender and Tea tree oils in the treatment of young women affected by mild idiopathic hirsutism (2012) (6)
Effect of digoxin on the in vitro secretion of renin and angiotensin II/III immunoreactivity by the human adrenal gland. (1992) (5)
Free urinary cortisol radioimmunoassay (application in the diagnosis of adrenal diseases). (1978) (5)
Patterns of ACTH response to oCRH in Cushing's disease: correlation with histological/immunocytochemical findings. (1994) (5)
Life events and neurocirculatory asthenia. A controlled study (1998) (5)
Iodine Status in the Elderly: Association with Milk Intake and Other Dietary Habits (2016) (5)
Skeletal effects of oral anticoagulants. (2009) (5)
Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma (2005) (5)
Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma (2005) (4)
Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus (2018) (4)
Advances in medical treatment of Cushing’s disease (2007) (4)
Effect of short and long-term administration of lisuride in Cushing’s disease (1985) (4)
Effect of verapamil on the aldosterone-stimulating properties of metoclopramide: in vitro and in vivo studies. (1986) (4)
Raloxifene and cardiovascular health: its relationship to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women. (2005) (4)
Effect of metergoline on the aldosterone-stimulating properties of metoclopramide. (1983) (4)
Cortical adrenal mitochondrial morphology changes in functional state: new insights (2013) (4)
The report of an Italian family with heterozygous protein C deficiency. (1988) (4)
Hypertension due to adrenal enzymatic defects. (1982) (4)
Effect of naloxone on the adrenal cortex in primary aldosteronism. (1988) (4)
Effect of a synthetic substituted alpha 1-18 ACTH on mineralocorticoid secretion. (1980) (3)
Morphometric dual-energy X-ray absorptiometry (MXA) for identification of vertebral fractures. (2007) (3)
An ultrastructural stereological study of accessory adrenocortical glands in bilaterally adrenalectomised rats. (1989) (3)
Considerations in Diagnosis of Cushing Syndrome—Reply (2001) (3)
Analysis of geospatial behaviour of visitors of urban gardens: is positioning via smartphones a valid solution? (2021) (3)
PROMPT: a prospective study to assess efficacy and safety of metyrapone in endogenous Cushing's syndrome (2018) (3)
Reactive nitrogen species in the chemical biology of sperm functions (2008) (3)
Foreword. Glucocorticoid-induced osteoporosis. (2008) (3)
Effects of naloxone on adrenal cortex regulation in patients with primary aldosteronism (1988) (3)
Asymptomatic primary hyperparathyroidism: surgical and medical management. (2011) (3)
CHROMOSOME-11 ABNORMALITIES IN SOMATOTROPHINOMAS FROM PATIENTS WITH ACROMEGALY (1991) (2)
Primary hyperparathyroidism and skeleton. Foreword. (2011) (2)
Hypogonadism and reduced bone mineral density in heterozygous H63D mutation in the HFE gene: an unusual presentation of hereditary hemochromatosis. (2006) (2)
Hypertension in Cushing’s Syndrome (2020) (2)
Factor XII activation after DDAVP. (1990) (2)
Effects of prolonged sodium restriction on the morphology and function of rat adrenocortical autotransplants (1991) (2)
Multiple endocrine neoplasia type 2 syndromes (MEN 2): Results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes (European Journal of Endocrinology 163 (301-308)) (2010) (2)
Inhibition of pituitary beta-endorphin by ACTH and glucocorticoids. (1990) (2)
Metyrapone treatment in endogenous Cushing’s syndrome. Results from a prospective multicenter, open-label, phase III/IV study: Prompt (2020) (2)
Serum levels of calcitonin in Cushing’s syndrome (1986) (2)
EFFECTS OF NALOXONE ON THE PITUITARY‐ADRENAL AXIS IN PATIENTS WITH DEXAMETHASONE‐SUPPRESSIBLE HYPERALDOSTERONISM (1987) (2)
Effect of benazepril on beta-endorphin in essential hypertension (1989) (2)
The Prevalence of HTLV-III and HTLV-I Antibodies in Serum of Hemophiliacs (1985) (2)
Pituitary microadenomas: Surgical results and morphological findings (2005) (2)
Evaluation and implications of salt intake and excretion (2019) (2)
[Diaxozide-induced acute stimulation of plasma renin activity in renal veins for diagnosis and prognosis in hypertensive patients (author's transl)]. (1979) (1)
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors (2017) (1)
Low-dose short synacthen test with salivary cortisol in patients with suspected central adrenal insufficiency (2021) (1)
Metyrapone treatment in endogenous Cushings syndrome. Long term efficacy and safety results of the extension of the phase III/IV study PROMPT (2021) (1)
Role of vitamin K on biochemical markers, bone mineral density, and fracture risk. (2007) (1)
The Adrenal Glands (2016) (1)
DIAGNOSIS AND TREATMENT OF CUSHINGS-SYNDROME - FROM THE SYMPOSIUM CUSHINGS-SYNDROME CURRENT CLINICAL PROBLEMS HELD IN PADOVA IN OCTOBER, 19-20, 1990 (1992) (1)
The quality of life in acromegaly. (2003) (1)
Effects of a calcium antagonist on the pituitary-adrenal axis. (1993) (1)
Long-term efficacy of pasireotide in a patient with Cushing's disease and diabetes: results in the short term are not always predictive of long-term response (2013) (1)
Role of clinical risk factors and polymorphisms in glucocorticoid receptor gene in the determining the risk of developing new-onset diabetes after kidney transplantation (2014) (1)
Type I and type II disease in congenital factor XIII deficiency (1986) (1)
Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment (2021) (1)
Effects of two different angiotensin II antagonists on aldosterone secretion by isolated perfused rat zona glomerulosa cells. (1981) (1)
Is the dopaminergic regulation of aldosterone truly mediated by potassium (1981) (1)
Gene therapy for thyroid cancer (2006) (1)
[Endocrinology of aldosterone]. (2005) (1)
Pituitary-directed medical treatment of Cushing’s disease (2009) (1)
A new slow-release formulation of lanreotide (autogel) in patients with active acromegaly: preliminary results of a multicenter, open clinical study (2003) (1)
[Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets]. (1992) (1)
Endocrinopathy-induced osteoporosis. Impact on health and economics of osteoporosis. (2010) (1)
Metabolic syndrome among patients with primary aldosteronism: a common feature? (2006) (0)
16 Effect of Atrial Natriuretic Factor (ANF) on aldosterone secretion: in vitro and in vivo studies (1985) (0)
Quality of life and psychological distress in patients treated for pituitary disease. (2007) (0)
Le masse incidentali del surrene (2000) (0)
Endocrinopathy-induced osteoporosis. Fourth National Meeting, Ancona, Italy, September 25-26, 2008. (2009) (0)
Title Page / Table of Contents / Preface (2010) (0)
The medical treatment with pasireotide in Cushing's disease: an Italian multicenter experience based on [ldquo]Real Word Evidence[rdquo] (2016) (0)
Acknowledgement to Reviewers (2009) (0)
Subject Index Vol. 54,1997 (1997) (0)
Autonomic impairment in idiopathic diabetes insipidus (2017) (0)
Dexamethasone-suppressible hyperaldosteronism: Pathophysiology, clinical aspects, and new insights into the pathogenesis (1987) (0)
The metabolic effects of ghrelin and glucocorticoids are mediated by AMP-activated protein kinase (AMPK) and endogenous cannabinoids (2008) (0)
SUN-LB97 Targeted Metabolomics as a Screening Tool in the Diagnosis of Endocrine Hypertension (2020) (0)
Faculty Opinions recommendation of Modified-release hydrocortisone to provide circadian cortisol profiles. (2009) (0)
Free thiols in human spermatozoa: correlation with Na+/K+-ATPase, Ca2+-ATPase activities and sperm motility (2009) (0)
Clotting and fibrinolytic behaviour in cushing's syndrome (1992) (0)
Genetic Variants in Primary Aldosteronism: 3.2 (2005) (0)
Diagnostic accuracy of captopril challenge test and saline infusion test in patients at high risk for primary aldosteronism (2019) (0)
Contents, Vol. 54, 1997 (1995) (0)
Urinary free cortisone as a potential biomarker in diagnosing patients with mild Cushing's syndrome (2015) (0)
T05-P-01 Sexual symptoms in endocrine diseases (2008) (0)
Unilateral primary aldosteronism considerations about the diagnostic criteria, adrenalectomy, and short and long time biochemical and clinical evaluation (2021) (0)
Corticotropin releasing factor effects on pituitary-adrenal axis before and after ketoconazole in cushing's syndrome (1986) (0)
Pro-gamma-MSH levels in various disorders of pituitary-adrenal axis (1990) (0)
9. Clinical aspects217. Effect of metoclopramide on plasma aldosterone: in vivo and in vitro studies (1978) (0)
Role of invasive and non-invasive diagnostic tests in differential diagnosis of ACTH-dependent Cushing's syndrome (2019) (0)
Outcome of patients with adrenocortical cancer after discontinuation of adjuvant mitotane therapy (2017) (0)
Diagnostic performance of late-night salivary cortisol measured by automated chemiluminescenze immunoassay (2014) (0)
7.20 Adiponectin Gene Variants in the Metabolic Syndrome of Patients with Primary Aldosteronism and Essential Hypertension (2007) (0)
Pitfalls in website information on dietary sodium restriction (2022) (0)
Thyroid Neoplasm (2018) (0)
Is this a seizure ? Case report (2017) (0)
Glucocorticoid receptor gene polymorphisms and bone mineral density in hpa axis disorders (2008) (0)
Growth hormone receptor and type 1 IGF receptor in human somatotroph tumours (2002) (0)
A reappraisal of second line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: the role of three dynamic tests (2015) (0)
Subject Index, Vol. 39, 1993 (1993) (0)
Dynamic testing for differential diagnosis of ACTH-dependent Cushing Syndrome: a systematic review and meta-analysis. (2022) (0)
GH secretagogues and hypothalamo-pituitary-adrenal axis (2003) (0)
Pathogenetic mechanisms of hypertension in Cushing's syndrome. (1990) (0)
Free urinary cortisol radioimmunoassay (1978) (0)
Effects of gender on clinical and biochemical features in Cushing's disease (2008) (0)
M011 Dexamethasone suppression test and long-PCR of chimeric gene for the diagnosis of glucocorticoid-remediable aldosteronism (GRA) in patients with primary aldosteronism (PA) (1998) (0)
Acute pasireotide suppression test in patients with Cushing's disease: a role in predicting long-term efficacy? (2014) (0)
Reduction of the 10-year probability of fracture predicted by FRAX[reg] and bone mass recovery in patients with Cushing's Syndrome after 24 months from cure of hypercortisolism (2012) (0)
4D.04 GENETIC PROFILING OF OMENTAL ADIPOSE TISSUE IN PATIENTS WITH PRIMARY ALDOSTERONISM AND CANDIDATE GENES FOR CARDIOMETABOLIC COMPLICATIONS (2010) (0)
Effect of short- and long-term treatment with pasireotide on hemochrome in patients with Cushing's disease (2013) (0)
A single-centre 10-years experience with pasireotide in Cushing[apos]s disease: patients characteristics and outcome (2015) (0)
Adrenocortical scintigraphic characterization of incidentally discovered adrenal massess (1996) (0)
Acknowledgement of reviewers 2013 (2014) (0)
Contents, Vol. 39, 1993 (1993) (0)
Glucose metabolism in Cushing ’ s syndrome Glucose metabolism abnormalities in Cushing ’ s syndrome : from molecular basis to clinical management (2017) (0)
The metabolic changes induced by glucocorticoids: involvement of AMP-activated protein kinase (2007) (0)
Erratum to: Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women (2005) (0)
Different biological and functional features in patients with Cushing's disease harboring micro- or macro-adenomas (2018) (0)
Comparison of salivary cortysol by chemiluminensce and mass spectometry in hypercortilosism (2012) (0)
Major Depression Associated with Cushing's Disease (1996) (0)
Subject Index, Vol. 72, Supplement 1, 1985 (1985) (0)
JCEM ARCHIVEApproach to the Patient with Possible Cushing's Syndrome (2011) (0)
Cortical adrenal mitochondrial morphology changes in functional state: new insights (2012) (0)
8. Patient with Possible Cushing's Syndrome (2012) (0)
RNA interference inhibits VEGF and EG-VEGF expression of H295R human adrenocortical carcinoma cell line (2008) (0)
Timing of total thyroidectomy in RET gene carriers < 18 years of age (2013) (0)
Fine-needleaspirationcytologyofadrenalmasses: Are-assessmentwithhistologicalconfirmation (2012) (0)
Transcriptional targeting in cancer gene therapy: Lessons from gliomas and thyroid tumors (2000) (0)
[Plasma renin activity in renal veins in different types of arterial hypertension (author's transl)]. (1976) (0)
Endocrinologia dell'aldosterone (2005) (0)
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy (2018) (0)
Metastatic Medullary Thyroid Cancer, Somatostatin Analogues and Markers (2016) (0)
Effect of rat adrenal cortex stimulation or inhibition of steroidogenesis: new perspectives on the steroidogenic function (2009) (0)
[Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)]. (1976) (0)
Contents, Vol. 72, Supplement 1, 1985 (1985) (0)
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal 1 hyperplasia due to 21-hydroxylase deficiency 2 3 Authors : (2016) (0)
Alpha-1 adrenergic blockade: a possible mechanism of action of dopaminergic drugs on ACTH secretion (1985) (0)
Activated partial thromboplastin time as determined by a chromogenic substrate (Parthochrom): Comparison with a conventional clotting method (1991) (0)
EVIDENCE FOR SHORT-LOOP AUTOREGULATION OF ADRENOCORTICOTROPIN IN MAN BY IMMUNORADIOMETRICASSAY AND RADIOIMMUNOASSAYS (1992) (0)
GENETIC PROFILING OF OMENTAL ADIPOSE TISSUE IN PATIENTS WITH PRIMARY ALDOSTERONISM AND CANDIDATE GENES FOR CARDIOMETABOLIC COMPLICATIONS: 4D.04 (2010) (0)
PRIMARY ALDOSTERONISM AND ESSENTIAL HYPERTENSION: ASSESSMENT OF THE GLOBAL CARDIOVASCULAR RISK AT DIAGNOSIS AND FOLLOW-UP: PP.39.287 (2011) (0)
[Adrenal phlebography in primary hyperaldosteronism]. (1975) (0)
Clinical Symposium (2004) (0)
Daily and nightly urinary free cortisol ratio as a marker of the hypothalamic-pituitary-adrenal (HPA) axis activity in abdominal obesity (2008) (0)
9-CIS retinoic acid decreases pomc expression and cell viability in experimental model of ectopic cushing syndrome (2020) (0)
ORIGINAL RESEARCH—ED PHARMACOTHERAPY The ENDOTRIAL Study: A Spontaneous, Open-Label, Randomized, Multicenter, Crossover Study on the Efficacy of Sildenafil, Tadalafil, and Vardenafil in the Treatment of Erectile Dysfunction (2009) (0)
Cardiac Findings in Cushing ’ s Syndrome Left Ventricular Structural and Functional Characteristics in Cushing ’ s Syndrome (2016) (0)
[Indications for study of adrenal function by measurement of the cortisol secretion rate]. (1976) (0)
Subject Index Vol. 92, 2010 (2010) (0)
Exosomal hsa-miR-483-5p and hsa-miR-101 are potential minimally invasive biomarkers of adrenocortical carcinoma (2017) (0)
Gene polymorphisms related to metabolic and cardiac complications in patients with primary aldosteronism (2005) (0)
Subject Index, Vol. 6 (Suppl. 1), 1986 (1986) (0)
Metabolic parameters in patients with primary aldosteronism: relation to snps of the adiponectin gene (2006) (0)
Does major depressive disorder cause osteoporosisin a young man (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Marco Boscaro?

Marco Boscaro is affiliated with the following schools:

University of Padua

Marco Boscaro's Academic­Influence.com Rankings

Why Is Marco Boscaro Influential?

Marco Boscaro's Published Works

Published Works

What Schools Are Affiliated With Marco Boscaro?

Marco Boscaro's AcademicInfluence.com Rankings